Literature DB >> 29767147

Homeostatic responses to amino acid insufficiency.

Tracy G Anthony1.   

Abstract

This article provides a brief overview describing how two key signaling pathways, namely the integrated stress response and the mammalian target of rapamycin complex 1, work together to facilitate cellular adaptation to dietary amino acid insufficiency. A deeper understanding of these mechanisms is leading to identification of novel targets which aid in disease treatments, improve stress recovery and increase health span through slowed aging and enhanced metabolic fitness.

Entities:  

Keywords:  Activating transcription factor 4; Asparaginase; Eukaryotic initiation factor 2; GCN2; Integrated stress response; mTOR

Year:  2015        PMID: 29767147      PMCID: PMC5945978          DOI: 10.1016/j.aninu.2015.10.001

Source DB:  PubMed          Journal:  Anim Nutr        ISSN: 2405-6383


  20 in total

1.  The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid.

Authors:  Feifan Guo; Douglas R Cavener
Journal:  Cell Metab       Date:  2007-02       Impact factor: 27.287

2.  Assessment of mitochondrial biogenesis and mTORC1 signaling during chronic rapamycin feeding in male and female mice.

Authors:  Joshua C Drake; Frederick F Peelor; Laurie M Biela; Molly K Watkins; Richard A Miller; Karyn L Hamilton; Benjamin F Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-08       Impact factor: 6.053

3.  General control nonderepressible 2 (GCN2) kinase protects oligodendrocytes and white matter during branched-chain amino acid deficiency in mice.

Authors:  Pengxiang She; Piyawan Bunpo; Judy K Cundiff; Ronald C Wek; Robert A Harris; Tracy G Anthony
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

4.  Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.

Authors:  Rachel B Reinert; L Morgan Oberle; Sheree A Wek; Piyawan Bunpo; Xue Ping Wang; Izolda Mileva; Leslie O Goodwin; Carla J Aldrich; Donald L Durden; Margaret A McNurlan; Ronald C Wek; Tracy G Anthony
Journal:  J Biol Chem       Date:  2006-08-24       Impact factor: 5.157

5.  The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment.

Authors:  Gabriel J Wilson; Piyawan Bunpo; Judy K Cundiff; Ronald C Wek; Tracy G Anthony
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-03       Impact factor: 4.310

Review 6.  Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

Authors:  Mukundh N Balasubramanian; Elizabeth A Butterworth; Michael S Kilberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

Review 7.  ATF4-dependent transcription mediates signaling of amino acid limitation.

Authors:  Michael S Kilberg; Jixiu Shan; Nan Su
Journal:  Trends Endocrinol Metab       Date:  2009-09-30       Impact factor: 12.015

8.  Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2.

Authors:  Tracy G Anthony; Brent J McDaniel; Rachel L Byerley; Barbara C McGrath; Douglas R Cavener; Margaret A McNurlan; Ronald C Wek
Journal:  J Biol Chem       Date:  2004-06-22       Impact factor: 5.157

Review 9.  Remodeling of lipid metabolism by dietary restriction of essential amino acids.

Authors:  Tracy G Anthony; Christopher D Morrison; Thomas W Gettys
Journal:  Diabetes       Date:  2013-08       Impact factor: 9.461

10.  SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1.

Authors:  Manuele Rebsamen; Lorena Pochini; Taras Stasyk; Mariana E G de Araújo; Michele Galluccio; Richard K Kandasamy; Berend Snijder; Astrid Fauster; Elena L Rudashevskaya; Manuela Bruckner; Stefania Scorzoni; Przemyslaw A Filipek; Kilian V M Huber; Johannes W Bigenzahn; Leonhard X Heinz; Claudine Kraft; Keiryn L Bennett; Cesare Indiveri; Lukas A Huber; Giulio Superti-Furga
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.